A Pilot Study of Stereotactic Body Radiotherapy (SBRT) Combined with a PD-L1 Antibody Durvalumab (D) and a CTLA-4 antibody Tremelimumab (T) To Treat Metastatic Anaplastic Thyroid Cancer (ATC)

Authors :: Wanqing Iris Zhi
David G. Pfister
C.J. Tsai
V. Wu
A.Y. Ho
T. Brinkman
Eric J. Sherman
Nancy Y. Lee
James Vincent Fetten
Nadeem Riaz
Source :: International Journal of Radiation Oncology*Biology*Physics. 105:S19
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Tools